Artivion | CRY - SCHULD





SCHULD Veränderung Datum
Abbott USD 34.05B 20.19B 2026-03
Accuray USD 170.24M 4.52M 2024-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.69B 93M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Inogen USD 0 0 2022-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Mesa Laboratories USD 204.98M 7.27M 2024-09
Orthofix International USD 137.23M 338K 2024-09
Pfizer USD 63.19B 536M 2026-06
ResMed USD 843.17M 4.55M 2026-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
Terumo JPY 379.8B 219.92B 2026-03
Trinity Biotech USD 137.98M 37.22M 2025-12